Topical Silver Sulfadiazine Formulations with Improved Efficacy and Toxicity Prof
Award amount
$270,598Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Novion Technologies
- Proposal award date
- 2014-09-25
- Contract end date
- 2016-09-22
- UEI
- WQWMDUXKY7K3
- Solicitation number
- PA14-077
- Topic code
- 300
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Research funding history
2 SBIR/STTR records share this UEI (2013–2014). Reported award amounts total $619,817. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services